Dean Alan Cater, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1001 Lincoln Hwy, Rochelle, IL 61068 Phone: 815-562-2030 Fax: 815-562-2030 |
Dr. Bruce Anthony Norkus, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1181 N 8th St, Rochelle, IL 61068 Phone: 815-562-8733 |
Dr. Shazeen Pardesi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 409 Lincoln Hwy, Rochelle, IL 61068 Phone: 815-261-6058 |
Dr. Seyed Hamed Mirzamani, DMD Dentist Medicare: Medicare Enrolled Practice Location: 223 E Il-38, Rochelle, IL 61068 Phone: 815-561-6058 |
Dr. Scott R Wilson, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1215 Currency Ct, Rochelle, IL 61068 Phone: 815-562-2474 |
Dr. Denis David Anderson, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1211 Currency Ct, Suite 3, Rochelle, IL 61068 Phone: 815-562-8774 Fax: 815-561-8150 |
Mohamed Wahba Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 223 E Il-38, Rochelle, IL 61068 Phone: 815-561-6058 |
Dr. James C Dunkel, DDS, MS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 409 Lincoln Hwy, Rochelle, IL 61068 Phone: 815-562-7582 Fax: 815-562-9742 |
Israa Altameemi Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1223 N Caron Rd, Rochelle, IL 61068 Phone: 815-562-7582 Fax: 815-562-9742 |
Dr. Max Marco Tejeda-nichols, C.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 409 Lincoln Hwy, Rochelle, IL 61068 Phone: 815-562-9742 |
News Archive
New findings will help to identify the genetic causes of brain disorders: researchers at the Universities of Basel, Bonn and Cologne have presented a systematic catalog of specific variable locations in the genome that influence gene activity in the human hippocampus, as they report in the journal Nature Communications.
An international research team, led by Dartmouth's Peter A. Kaufman, MD, published findings today in the Journal of Clinical Oncology demonstrating that, while not superior to capecitabine, eribulin is an active and well-tolerated therapy in women with metastatic breast cancer (MBC) receiving this therapy as a first, second, or third line chemotherapy regimen.
A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy to inhibit the ability of SARS-CoV-2 to invade human cells.
The constant battle against infectious pathogens has had a decisive influence on the human immune system over the course of our evolution.
› Verified 2 days ago